Anna Louise French is Director of Jasper Therapeutics, Inc.. Currently has a direct ownership of 23,750 shares of JSPR, which is worth approximately $616,550. The most recent transaction as insider was on Apr 14, 2023, when has been sold 7,000 shares (Voting Common Stock) at a price of $1.48 per share, resulting in proceeds of $10,360. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 23.8K
0% 3M change
0% 12M change
Total Value Held $616,550

Anna Louise French Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 14 2023
SELL
Open market or private sale
$10,360 $1.48 p/Share
7,000 Reduced 22.76%
23,750 Voting Common Stock
Oct 12 2022
BUY
Grant, award, or other acquisition
-
30,750 Added 50.0%
30,750 Voting Common Stock
ALF

Anna Louise French

Director
Redwood City, CA

Track Institutional and Insider Activities on JSPR

Follow Jasper Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells JSPR shares.

Notify only if

Insider Trading

Get notified when an Jasper Therapeutics, Inc. insider buys or sells JSPR shares.

Notify only if

News

Receive news related to Jasper Therapeutics, Inc.

Track Activities on JSPR